ArticleJournal of immunology research2022

FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma.

Ting Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.